George P. Denny III serves as Executive at Brooklyn ImmunoTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, George P. Denny III has executed 4 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 14, 2021 involved purchasing 1 shares valued at $12.
George P. Denny III currently holds 3 shares of Brooklyn ImmunoTherapeutics, Inc. (BTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George P. Denny III has been a net seller of BTX stock. They have purchased $40 and sold $1.2M worth of shares.
George P. Denny III's most recent insider trade was on Jul 14, 2021, when they purchased 1 shares at $11.99 per share.
Get notified when new Form 4 filings are submitted
| $14.11 |
| Discretionary |
| Jul 8, 2021 | BTX | $14 | Purchase | 1 | $14.35 | Discretionary |
| Jul 6, 2021 | BTX | $1.2M | Sale | 75,000 | $16.06 | Discretionary |